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Two sets of traditional Greek sheep milk yoghurt were produced: the ﬁrst one (YC) using normal yoghurt culture (Lactobacillus del-
brueckii subsp. bulgaricus !10.13 and Streptococcus thermophilus !10.7) and the second (PR) with the same normal culture mixed with
Lactobacillus paracasei subsp. paracasei DC412. YC and PR had similar physicochemical properties and proteolysis patterns throughout
storage. Both products showed similar peptide proﬁles by RP-HPLC but quantitative diﬀerences were observed in respect to storage
time. Single-strain cultures of the microorganisms used showed similar peptide proﬁles for both lactobacilli, yet L. delbrueckii subsp.
bulgaricus was the most proteolytic of all three microorganisms. The peptide content and the ACE-inhibitory activity of the water-soluble
extracts of yoghurts, YC and PR, increased throughout storage. Major peptides were identiﬁed from yoghurt PR and from the separate
cultures of L. delbrueckii subsp. bulgaricus and L. paracasei subsp. paracasei. Most of these peptides were derived from b-casein. A pep-
tide, b-CN f114-121, with well-established ACE-inhibitory and opiate-like activity was identiﬁed in yoghurt PR. Further identiﬁed pep-
tides were regarded as potential ACE-inhibitors according to their sequence.
Introductionbbreviations: ACE, angiotensin-I converting enzyme; %IACE, percent-
ge of inhibition of ACE; IC50, the concentration needed to inhibit 50% of
e enzyme activity; RP-HPLC, reversed-phase high performance liquid
hromatography; TCA, trichroloacetic acid; DH, degree of hydrolysis;
SE, water soluble extract; OPA, o-phthaldialdehyde; TFA, triﬂuoro-
cetic acid.
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E-mail address: annavafo@agro.auth.gr (A. Vafopoulou-Mastrojian-
aki).In recent years the consumption of yoghurt has
increased rapidly owing to the fact that this dairy product
fulﬁls many of the current dietary needs. It is a ready-to-eat
food, relatively low in fat and rich in nutritional compo-
nents. Furthermore, the demand for functional foods has
been boosted in recent years as a result of growing aware-
ness among consumers of the link between diet and health
(FitzGerald, Murray, & Walsh, 2004). Yoghurt has proved
to be an excellent vehicle for the production of such func-
tional food, especially when it contains probiotic bacteria.
It is also possible that the beneﬁcial health eﬀects of
yoghurt can be increased, based on the peptides that are
produced during fermentation and storage. More recently,
a great interest has been focussed on peptides that can
lower the blood pressure in hypertensive patients, since
hypertension is a disease that is increasing at high rates,
especially in the developed countries (FitzGerald et al.,
2004).
The mechanism of action of these peptides is based on
the inhibition of angiotensin-I converting enzyme (ACE,
E.C. 3.4.15.1), yet the possibility cannot be excluded that
their activity may include many more complex mecha-
nisms that may promote further beneﬁcial eﬀects for con-
sumer health (Fuglsang, Nilsson, & Nyborg, 2003a; Ija¨s
et al., 2004; Vermeirssen, Van Camp, & Versraete,
2004). In particular, ACE is an enzyme that has a key role
in the rennin-angiotensin system, which in turn regulates
the arterial blood pressure and the equilibrium of water
and salt in the body. An increase in blood pressure is
observed when the enzyme catalyses the hydrolysis of
angiotensin I to angiotensin II, a strong vasoconstrictor
agent, and the degradation of bradykinin, which has vaso-
dilative action, to a greater extent than needed (Coates,
2003).
Many peptides with antihypertensive action have been
characterised upon fermentation of milk with diﬀerent
microorganisms, or by the action of pure proteinases on
milk proteins. Some of these peptides have been studied
for their eﬀect on spontaneously hypertensive rats, or even
on small groups of human volunteers, showing positive
results (FitzGerald et al., 2004; Vermeirssen et al., 2004).
Sheep milk is of great importance to Greece and has
been a key raw material for the production of yoghurt with
good sensory characteristics (Alichanidis & Polychronia-
dou, 1996). Although the hydrolysis of sheep milk proteins
in cheese has been extensively investigated, there is little
information available on proteolysis in sheep milk yoghurt,
especially traditional Greek yoghurt.
Hence, the aim of this study were: (a) to investigate the
proteolysis during storage of traditional sheep milk Greek
yoghurt and the eﬀect thereon of a probiotic strain (Lacto-
bacillus paracasei subsp. paracasei DC412) when used as an
adjunct to the normal yoghurt culture; (b) to identify the
major peptides produced during storage of the yoghurt
products; (c) to measure the ACE-inhibitory activity of
the products.
The milk for yoghurt production was purchased from a
small local yoghurt industry and was tested for pH (Con-
sort C830, Belgium), titratable aciditity (AOAC, 1990),
somatic cell count (Fossomatic, A/S Foss Electric, Den-
mark) and chemical composition (Milkoscan 104, A/S Foss
Electric, Denmark). The same milk was used for the sub-
cultures of the microorganisms.
Lactobacillus delbrueckii subsp. bulgaricus !10.13 and
Streptococcus thermophillus !10.7 were isolated from goat
milk yoghurt. L. paracasei subsp. paracasei DC412 was
used as adjunct. All strains were identiﬁed by phenotypic
criteria and SDS–PAGE of the whole cell proteins, while
Materials and methodsL. paracasei was additionally identiﬁed by rRNA-targeted
oligonucleotide probe hybridization (Xanthopoulos, 2002;
Xanthopoulos, Ztaliou, Gaier, Tzanetakis, & Litopoulou-
Tzanetaki, 1999). L. paracasei was selected for this experi-
ment following in vitro trials regarding the probiotic poten-
tial of a series of isolates from infant faeces (Xanthopoulos,
Litopoulou-Tzanetaki, & Tzanetakis, 2000). All strains
belong to the collection of the Laboratory of Food Micro-
biology and Hygiene, Aristotle University of Thessaloniki,
Greece.
Lactobacillus strains were ﬁrst subcultured in MRS
broth, and Streptococcus in M17. All the strains were then
subcultured twice in reconstituted skim milk (10%, w/v),
followed by a ﬁnal subculture in full fat sheep milk, previ-
ously heated at 90 C for 30 min, in order to be better
adapted to the sheep milk environment. All the subcultures
were done at 37 C for 18 h.Set type traditional Greek yoghurt was produced with
full fat sheep milk heated at 85–90 C for 30 min under
constant stirring. The heated milk was immediately distrib-
uted in 350 ml plastic retail containers and left to cool at
47 C. Subsequently, a 2.5% (v/v) inoculum was introduced
into each container.
Two sets of yoghurts were produced. The ﬁrst set (YC),
contained L. delbrueckii subsp. bulgaricus and S. thermo-
philus (1:1). For the second set (PR), the same strains as
for YC yoghurt were used, with addition of L. paracasei
subsp. paracasei (2:2:1) (Table 1). The yoghurts were incu-
bated at 42 C for about 4 h, until pH 4.7 was reached.
They were maintained at room temperature for 1 h, sealed
and stored at 4 C. Samples were taken at 1 (1 h after
yoghurts reached pH 4.7), 2, 5, 10, 19 and 26 days of stor-
age and subjected to physicochemical analysis. The
yoghurt-making trials were repeated three times.
For investigation of the proteolytic pattern of each
strain used in yoghurt making, three single-strain fer-
mented milks were produced from the same sheep milk,
as follows: after heating, the milk was cooled to 37 C,
inoculated (2% v/v) with one of the three strains and incu-
bated at 37 C for 18 h. The fermented milks were then
cooled to 4 C and used for peptide analysis. Cultures, per-
centage of inocula and fermentation temperatures for all
products manufactured are summarised in Table 1.The pH of yoghurt samples was measured with a Con-
sort pH meter (Consort C830, Belgium), acidity was
titrated with N/9 NaOH solution, total solids were deter-
mined by drying yoghurt samples at 102 C for 16 h
(IDF, 1996) and fat content was determined using van
Gulik’s method (Schwarz, Hageman, Hu¨ttig, Kellermann,
& Staege, 1950). Nitrogen content was determined by the
Table 1
Cultures, conditions and inocula used for the production of yoghurts and fermented milks
Strains inoculum Fermentation temperature (C)
Yoghurt (YC) 2.5% v/v 42
L. delbrueckii subsp. bulgaricus !10.13 and S. thermophillus !10.7
Yoghurt (PR) 2.5% v/v 42
L. delbrueckii subsp. bulgaricus !10.13 and S. thermophillus !10.7
and L. paracasei subsp. paracasei DC412
Fermented milk (FM1) 2% v/v 37
L. delbrueckii subsp. bulgaricus !10.13
Fermented milk (FM2) 2% v/v 37
S. thermophillus !10.7
Fermented milk (FM3) 2% v/v 37
L. paracasei subsp. paracasei DC412Kjeldahl method (AOAC, 1990) and the total protein was
calculated as follows: Kjeldahl N  6.38.
For monitoring the hydrolysis of proteins during stor-
age of yoghurts at 4 C, water-soluble extracts (WSEs) of
the samples were prepared according to the method pro-
posed by Kuchroo and Foxfor cheese (1982). The extracts
were lyophilised and kept at 25 C prior to further anal-
ysis. WSEs were also prepared from the fermented milks,
FM1, FM2 and FM3.
The concentration of the nitrogenous compounds pro-
duced by proteolysis (reported hereafter as peptides) in
the WSEs of yoghurts and related fractions was estimated
using the following methods:
(a) Kjeldahl method (N  6.38) (AOAC, 1990).
(b) OPA method (Church, Swaisgood, Porter, & Catig-
nani, 1983). The peptide concentration was calculated
from a standard curve prepared using casein peptone
(Casein peptone N1, Organotechnie, France) as a
reference.
(c) Direct spectrophotometric method (Scopes, 1974).
The absorbances of the WSEs were measured at 280
and 205 nm. The extinction coeﬃcient ðe1mg=ml205 Þ of
each extract was calculated using the equation
e1 mg=ml205 ¼ 27þ 120 ðA280=A205Þ. The peptide con-
centration (mg/ml) was then calculated by dividing
the absorbance at 205 nm by the extinction
coeﬃcient.
From the results obtained by each of the above meth-
ods, the degree of proteolysis was calculated using the
equation DH = AC/IC, where DH is the degree of hydro-
lysis, AC is the average concentration of peptides in the
WSE of each set of yoghurt at each storage time, and IC
is the average concentration of peptides in the WSE of
the same set of yoghurt at day 1 (1 h after the completion
of the fermentation).Finally, the concentration of peptides soluble in 12% tri-
chloroacetic acid (TCA) was determined as follows (Poly-
chroniadou, Michaelidou, & Paschaloudis, 1999): Ten ml
of each WSE were mixed with an equal volume of 24%
(w/v) TCA, the mixture was left overnight at 4 C, and
the precipitate ﬁltered through white ribbon ﬁlter paper
(Schleicher and Schuell, Dassel, Germany) and used for
the analysis by the Kjeldahl method (AOAC, 1990). Pep-
tide concentration was calculated (Kjeldahl N  6.38).
Freeze-dried samples of the WSEs of yoghurts and fer-
mented milks were dissolved in one half of their original
volume with deionised water, sonicated for 5 min and ﬁl-
tered through a 0.45 lm cellulose acetate ﬁlter.
Reversed-phase HPLC (RP-HPLC) was performed as
described by Michaelidou, Alichanidis, Urlaub, Polychro-
niadou, and Zerﬁridis (1998). A binary HPLC system
(LKB, Bromma, Sweden) was used, ﬁtted with a Nucleosil
C18 wide pore analytical column (5 lm, 30 nm, 250 
4 mm; Macherey-Nagel, Du¨ren-Germany) and a guard col-
umn (40  4 mm). Samples were applied using a Rheodyne
injector (Rheodyne 7125, Rheodyne Inc, Cotati CA-USA),
ﬁtted with a 50 ll loop. Eluent A was 0.1% (v/v) TFA in
deionised water and eluent B was 0.09% (v/v) TFA in a
mixture of 60:40 acetonitrile (HPLC gradient, Panreac
Quinica SA, Barcelona, Spain) and deionised water. Sepa-
ration was conducted at room temperature (20 C) at a
ﬂow rate of 0.8 ml/min with eluent A for 10 min and a lin-
ear gradient, from 0% to 80% of eluent B, for 80 min. The
column was ﬁnally eluted with 100% eluent B for 10 min.
The absorbance of the eluate was monitored at 214 nm,
using a variable wavelength spectrophotometric detector
(Fasma 525, Linear, USA), which was linked to a data
acquisition and processing system (Nelson Analytical
Inc., Paramus, NJ, USA).
Peptides were isolated and characterized, from the
WSEs of yoghurt PR at 2, 10 and 26 days of storage and
from the WSEs of the fermented milks, FM1 and FM3.
Fractions were collected manually on a peak basis from at
least 12 successive RP-HPLC runs of the selected WSEs
and dried in a vacuum concentrator. Homologous peaks
in RP-HPLC chromatograms of PR (at 2, 10, and 26 days),
FM1 and FM3, were numbered. The peptides in each frac-
tion were characterised by analysing the amino acid
sequence using the Edman procedure.
For further separation of a group of peaks at the begin-
ning of the chromatogram (0–10 min), the corresponding
fraction was collected manually from 15 successive RP-
HPLC runs, dried under vacuum, redissolved in deionised
water and fractionated again with the same system but with
a ﬂow rate of solvent A of 0.2 ml/min. The eluate was mon-
itored at 278 nm.
Peptides isolated by RP-HPLC (as described above)
were sequenced using a model 491 automated, pulsed
liquid-phase protein-peptide sequencer (Applied Biosys-
tems, Foster City CA, USA). Amino acids liberated were
detected as their phenylthiohydantoin derivatives. The par-
tial sequence thus obtained was checked against the
(known) sequence of caseins, so as to determine the most
likely cleavage site.
ACE inhibitory activity was determined by the method
of Cushman and Cheung (1971) as modiﬁed by Nakamura
et al. (1995), with some further modiﬁcations. Each assay
mixture (250 ll) contained the following components at
the indicated ﬁnal concentrations: (a) 180 ll of a hippu-
ryl-L-histidyl-L-leucine solution (5 mM) in sodium borate
(100 mM) (pH 8.3), buﬀer treated with 300 nM NaCl; (b)
50 ll of WSE or peak material or water as a blank; (c)
20 ll of a 2 mU ACE (from rabbit lung, Sigma–Aldrich,
St. Louis, MO, USA) aqueous solution. The mixture was
incubated at 37 C for 90 min and the reaction was stopped
with 250 ll of 1 N HCl. The produced hippuric acid was
extracted with 1.7 ml of ethyl acetate, heat-evaporated at
100 C for 15 min, redissolved in 1 ml of distilled water
and measured spectrophotometrically at 228 nm. TheTable 2
Composition of sheep milk before and after heating at 85–90 C for 30 min a
Chemical characteristics Milk
Before thermal process
Fat (%) 5.93 ± 0.15
Protein (%)b 5.8 ± 0.09
Total solids (%) 16.7 ± 0.23
Lactose (%) 4.28 ± 0.13
pH 6.6 ± 0.03
Lactic acid (%) 0.19 ± 0.005
Somatic cells/ml 350,000
a Analyses were performed in triplicate. Values are means ± SD.
b Protein = total nitrogen  6.38.activity of each sample was tested in triplicate. The ACE-
inhibitory activity was expressed as percentage of inhibi-
tion of ACE activity (%IACE) or calculated as the protein
concentration needed to inhibit 50% of the original ACE
activity (IC50).
Statistical analysis was performed using SPSS 12.0 for
Windows (SPSS Inc., Chicago, USA). Results were ana-
lysed by one or two-way analysis of variance. Diﬀerences
between the treatment means were compared at the 5%
level of signiﬁcance using LSD test.
The mean composition of sheep milk, before and after
heating and of yoghurts YC and PR, is given in Table 2.
During storage, the pH of both yoghurts decreased contin-
uously, reaching a ﬁnal value of ca. 3.8 (Fig. 1). Although
the time eﬀect was signiﬁcant (P < 0.05) for both yoghurts
and for all time intervals tested, the culture eﬀect was not
signiﬁcant, indicating that the use of L. paracasei subsp.
paracasei DC412 as an adjunct did not aﬀect the pH of
the product. Similar results were obtained for acidity.
Proteolysis during storage of yoghurts was estimated by
three diﬀerent methods: (a) the Kjeldahl method, (b) the
OPA method (Church et al., 1983) and (c) the direct spec-
trophotometric method (Scopes, 1974). Although the abso-
lute values obtained by the three methods for peptide
concentration were diﬀerent (P < 0.05), the degree of
hydrolysis calculated were similar (P > 0.05); at day 26,
the degree was about 1.5, indicating about 50% increase
of the concentration of peptides from day 1 for both YC
and PR. Despite this increase, the percentage of milk pro-
teins hydrolysed remained low; on day 26, the WSEs con-
tained only 10% of the total N of the yoghurt (data not
shown). For both yoghurts and for the whole storage per-
iod, the peptides soluble in 12% TCA composed more than
90% of the peptides of WSEs, indicating that most peptides
in the WSEs had low molecular weight.
Results and discussionnd of yoghurt after fermentation at 42 Ca
Yoghurt (YC and PR)
After thermal process
6.47 ± 0.07 6.6 ± 0.1
6.31 ± 0.12 6.34 ± 0.05
18.22 ± 0.17 18.05 ± 0.03
4.72 ± 0.05 –
6.55 ± 0.02 4.45 ± 0.03


































Fig. 1. pH and acidity of traditional Greek sheep milk yoghurts during
storage at 4 C. Yoghurt YC was inoculated with L. delbrueckii subsp.
bulgaricus !10.13 and S. thermophillus !10.7. Yoghurt PR was inoculated
with the previous two microorganisms and L. paracasei subsp. paracasei
DC412 as an adjunct. Vertical bars represent standard errors (n = 6).The WSEs of the yoghurts (YC and PR) at diﬀerent ages
were analysed by RP-HPLC. The peptide proﬁles obtained
were similar and only some quantitative diﬀerences were
observed, concerning the area of some peaks (data not
shown). In Fig. 2, representative chromatograms of 2, 10
and 26-day-old samples of PR are shown, together with
chromatograms of the fermented milks, FM1, FM2 and
FM3. Analysis of the last three chromatograms reveals that
there is a high degree of similarity between the peptide pro-
ﬁles of L. delbrueckii subsp. bulgaricus (FM1) and L. para-
casei subsp. paracasei (FM3) as far as the number and
retention times of the peaks are concerned. This observa-
tion, combined with the low proteolytic capacity of S. ther-
mophilus, may explain, at least partially, the minor
diﬀerences in peptide proﬁles of YC and PR yoghurts, as
mentioned above.
The chromatograms of WSEs of yoghurt PR (Fig. 2)
show that most of the peaks were formed by the second
day of storage. During storage the peaks increased in
height but no signiﬁcant changes in the chromatographic
proﬁle occurred.
Twelve peptides were identiﬁed, most of which origi-
nated from b-casein (Table 3). None of the identiﬁed pep-
tides was a phosphopeptide although other authors
identiﬁed phosphopeptides in other fermented milks (Chia-
nese et al., 2003; Courtin & Rul, 2004). On the other hand,
the absence of peptides originating from whey proteins in
yoghurt PR is a phenomenon that has also been reported
for other fermented milks (Bertrand-Harb, Ivanova, Dal-
galarrondo, & Heartlle, 2003; Chianese et al., 2003; Quiro´s,
Herna´ndez-Ledesma, Ramos, Amigo, & Recio, 2005).
In particular, eight peptides originated from b-casein.
Almost all of them had the same N-terminal sequence
(peaks 3, 5, 11, 12, 14, 15) as that of peptides released by
the action of lactococcal proteinases (Gobbetti, Ferranti,Smacchi, Goﬀredi, & Addeo, 2000; Juillard et al., 1995;
Kunji, Mierau, Hagting, Poolman, & Konings, 1996).
The peptide identiﬁed in peaks 6, 8 and 13 (as1-CN f1-8)
was the only peptide derived from as1-casein, and it was
possibly produced by the action of L. bulgaricus on sheep
as1-casein.
Only one peptide, as2-CN f79-82, was identiﬁed from
as2-casein. It was produced by L. bulgaricus and was co-
eluted in peak 6, together with peptide as1-CN f1-8.
Although peptide as1-CN f1-8 was also identiﬁed in other
peaks of the yoghurt PR, peptide as2-CN f79-82 was not
identiﬁed in yoghurt PR, possibly because it was further
hydrolysed by the other two microorganisms present in
the mixed bacterial culture.
Peptide j-CN f53-60 was the only identiﬁed peptide
derived from j-casein and it was found only in yoghurt
PR. From the evolution chromatograms (Fig. 2), it can
be seen that peptide j-CN f53-60 was probably produced
during the ﬁrst days of storage and its concentration rose
gradually up to day 26.
The possible presence of ACE-inhibitory peptides in
yoghurts YC and PR was ﬁrst investigated using WSEs as
testing material. The ACE-inhibitory activity of the WSEs
throughout storage (%IACE) is presented in Fig. 3. As
can be seen, the ACE-inhibitory activity increased during
storage and was positively correlated with the peptide con-
centration in WSEs. Similar results were found in a report
of 26 diﬀerent strains of lactic acid bacteria, where a high
correlation between the concentration of peptides and the
percentage of inhibition of ACE was shown (Fuglsang,
Rattray, Nilsson, & Nyborg, 2003b).
No signiﬁcant (P > 0.05) diﬀerences were found between
the two yoghurts in respect to ACE-inhibitory activity, a
fact that is supported by similarities in the chromatograms
of their WSEs. The concentration of peptides needed to
inhibit 50 % of ACE (IC50) ranged from 1.49 to 1.62 mg/
ml. The degree of inhibition of ACE of the WSEs and
the calculated IC50 values are in accordance with the results
reported by other researchers (Fuglsang et al., 2003b;
Herna´ndez-Ledesma, Amigo, Ramos, & Recio, 2004;
Herna´ndez-Ledesma, Martin-Alvarez, & Pueyo, 2003).
Leclerc, Gauthier, Bachelard, Santure, and Roy (2002)
found similar IC50 values, 1.15–1.68 mg/ml, from the
action of Lactobacillus helveticus on milk proteins.
To identify the peptides responsible for the inhibition of
ACE, the WSE of the 26-day-old yoghurt PR was sub-
jected to RP-HPLC analysis. Nine diﬀerent fractions were
collected and evaluated for their ACE-inhibitory activity
(Fig. 4). The material included in fraction 1, which had
the highest ACE-inhibition activity, was collected from
12 successive runs, lyophilised, redissolved and resubjected
to chromatography. Two fractions were obtained there-
from and were further tested for ACE-inhibitory activity.
Fraction 1.1 showed the highest inhibitory activity on





























































Fig. 2. RP-HPLC proﬁles of the water-soluble extracts obtained from single-culture fermented milks (A: FM3, L. paracasei subsp. paracasei DC412; B:
FM2, S. thermophilus !10.7; C: FM1, L. delbrueckii subsp. bulgaricus !10.13) and from yoghurt PR at 2 (D), 10 (E) and 26 (F) days of storage.
Chromatogram G is the proﬁle of the indicated part in chromatogram F under diﬀerent conditions (see Section 2). Material corresponding to the
numbered peaks was collected and identiﬁed.ACE and was further puriﬁed using diﬀerent chromato-
graphic conditions (see Section 2). The material of ﬁve
peaks (Fig. 4A–E) was collected and subsequently tested
for ACE-inhibitory activity.The peptide contained in peak B (previously numbered
as peak 18), showing the highest ACE-inhibitory activity
(IC50: 0.37 mg/ml), was sequenced. It corresponded to
YPVEPFTE, originating from b-casein (b-CN f114-121).
Table 3
Peptides identiﬁed in the water-soluble extracts of yoghurt PR and the single-strain fermented milks, FM1 (L. delbrueckii subsp. bulgaricus !10.13) and





Casein fragment Corresponding yoghurt or
fermented milk
1, 4, 10 Y PR, FM1, FM3
2 KAVPQ b-CN f176-180b FM3
3 GVPKVK b-CN f94-99 FM3
5, 11, 12 GVPKVKE b-CN f94-100 PR, FM1
6 RPKHPIKH as1-CN f1-8 FM1
YQKA as2-CN f79-82
7, 9 (T/H/Y/A)P 45 possible combinations from as1-CN,
as2-CN, b-CN, j-CN and b-lactoglobulin
PR
8, 13 RPKHPIKH as1-CN f1-8 PR
14 SQPK b-CN f166-169 PR
YQEP b-CN f191-194
15 DKIHPFAQ b-CN f47-54 PR
16 NQFLPYPY j-CN f53-60 PR
17 TQTPVVVP b-CN f78-85 PR
18 YPVEPFTE b-CN f114-121 PR










































Fig. 3. pH, peptide concentration of the water-soluble extracts (WSE, mg/ml) and percentage of inhibition of ACE (%IACE) during storage of yoghurts
YC and PR (means of six replications).Lebrun et al. (1995) isolated the same peptide by hydrolysis
of c-casein with trypsin; the peptide exhibited bradykinin-
potentiating eﬀects on isolated guinea-pig ileum and on
rat arterial blood pressure. Further research on this peptide
has shown that it is not only related to the inhibition of
ACE, but also possibly related to the inhibition of other
enzymes participating in the degradation of bradykinin
(Perpetuo, Juliano, & Lebrun, 2003). Injection of this pep-
tide into rats also presented an opiate-like activity by show-
ing a 2-fold increase of latency time to pain in the hot-plate
assay (Perpetuo et al., 2003).
According to literature data (Maeno, Yamamoto, &
Takano, 1996; Yamamoto, Maeno, & Takano, 1999), there
are existing reports on incidences of important decrease ofarterial blood pressure upon ingestion of peptides that had
shown low ACE-inhibitory activity in vitro. Furthermore,
processing of casein hydrolysates, derived from starter cul-
tures, with pepsin and trypsin, greatly increased the per-
centage of inhibition of ACE of these hydrolysates
(Pihlanto-Leppala, Rokka, & Korhonen, 1998). Therefore,
it seems likely that the combined action of diﬀerent prote-
olytic agents can lead to a greater inhibition of ACE com-
pared to the original product. Hence, we could speculate
that apart from peptide b-CN f114-121, ﬁve other
sequenced peptides could also act as ACE-inhibitors, if fur-
ther hydrolysed by the enzymes of the intestinal tract
(Table 4). For example, Minervini et al. (2003), found that
peptide as1-CN f1-4 has a high antihypertensive eﬀect




















































Fig. 4. RP-HPLC chromatogram of the water-soluble extracts of yoghurt PR after 26 days of storage: fractions collected are numbered and the
corresponding percentages of ACE-inhibitory activity (%IACE) are presented. The lower chromatogram is part of fraction 1 (dotted line, fraction 1.1)
under diﬀerent chromatographic conditions (absorbance at 278 nm; ﬂow rate 0.2 ml/min). Each peak of this chromatogram was collected separately and
the ACE-inhibitory activity tested.
Table 4








15 DKIHPFAQ DKIHPF Antihypertensive (IC50 257 lM) Gobbetti et al. (2000)
15 DKIHPFAQ DKIHP Antihypertensive (IC50 234 lg/ml, IC50
113 lM or 578 lM)
Quiro´s et al. (2005), Gomez-Ruiz
et al. (2004)
17 TQTPVVVP NIPPLTQTPV Antihypertensive (IC50 173 lM) Gobbetti et al. (2000)
2 KAVPQ SKVLPVPQ Antihypertensive (IC50 39 lM) Yamamoto et al. (1994)
6, 8, 13 RPKHPIKH RPKHPI Antihypertensive (IC50 40.3 lM) Minervini et al. (2003)
Residues in bold letters indicate sequence homology of fractions.in vitro (IC50: 30.1 lg/ml). This peptide is part of the
sequence of the, peptide as1-CN f1-8, which was identiﬁed
in peaks 6 of FM1 and 8 and 13 of yoghurt PR. Although
the relationship between structure and mechanism ofaction of the ACE-inhibitors is not yet clear, it seems likely
that the three C-terminal amino acids play an important
role. They are preferably hydrophobic amino acids (aro-
matic or with branched side chains) or the iminoacid
proline (Meisel, 1998). The peptides presented in Table 4 as
precursors of ACE-inhibitors, were selected, based on these
estimations.
Conclusion
In this study the proteolytic activity of L. delbrueckii
subsp. bulgaricus !10.13, S. thermophilus !10.7 and L.
paracasei subsp. paracasei DC412, in mixed or plain cul-
tures, was examined during their growth in sheep milk.
L. delbrueckii subsp. bulgaricus !10.13 was the most prote-
olytic, followed closely by L. paracasei subsp. paracasei
DC412, with similar proteolytic proﬁles. Examination of
the probiotic yoghurt for the presence of antihypertensive
peptides revealed the presence of a peptide, i.e. b-CN
f114-121, reported as having both antihypertensive and
opiate-like activity. Based on our results, it is suggested
that this traditional product may possess multifunctional
health eﬀects, due to the presence of probiotics and bioac-
tive peptides. Nevertheless, further investigation is needed
in order to demonstrate these health beneﬁts via in vivo tri-
als and clinical studies.
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